Clinical Study

Individualized Treatment For Nasopharyngeal Cancer Based On The Patient’S Dna

Posted Date: Oct 2, 2014

  • Investigator: Kevin Redmond
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This study is being done to see how people with your type of cancer respond to different types or levels of chemotherapy, based on a specific viral marker in their blood. This viral marker is called the Epstein Barr virus, (EBV). A more individualized approach to treating your type of cancer might be found using this blood marker.


To Be Eligible For This Study, Patients Must Have Nasopharyngeal Cancer (In The Head And Neck Region Of Your Body) That Has Not Spread To Other Parts Of Your Body


Head & Neck, Nrg-Hn001, Nasopharyngeal Carcinoma, Cancer

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.